CA
NZ
UK
AU
IND
US
Universal Health Services (NYSE:UHS) shares are indicated down 5.12% at $168.25 in premarket after third-quarter results that were mixed. Revenue of $4.73 billion, up 5.3%, and adjusted EPS of $5.22 were roughly in line with consensus of $5.15 to $5.31, but adjusted EBITDA of …
Absci Corporation (NASDAQ: ABSI) shares were trading at USD 10.51 on October 27, 2026, up 11.16%, with a relative volume at time of 2.01. The clinical-stage biopharmaceutical company announced interim Phase 1 data from its HEADLINE trial in June 2026, completed a public offering …
Beta Bionics (NASDAQ: BBNX) shares were trading at USD 21.41 on October 27, 2026, up 4.39%, with a relative volume at time of 2.55. The medical device company received an FDA Warning Letter in January 2026, began enrolling adults with type 2 diabetes in …
BioCryst (NASDAQ: BCRX) shares were trading at USD 8.01 on October 27, 2026, up 1.59%, with a relative volume at time of 2.28. The biotechnology company completed its merger with Astria Therapeutics on January 23, 2026, entered a navenibart license agreement with an affiliate …
CeriBell, Inc. (NASDAQ: CBLL) shares were trading at USD 27.03 on October 27, 2026, with a relative volume at time of 2.56. The medical technology company received a new FDA 510(k) clearance in June 2026, entered into a Credit Agreement with MidCap Funding IV …
Enliven Therapeutics, Inc. (NASDAQ: ELVN) shares were trading at USD 43.95 on October 27, 2026, up 5.93%, with a relative volume at time of 2.32. The clinical-stage biopharmaceutical company closed a public offering on June 15, 2026 and filed its quarterly report for the …
Enovis Corporation (NYSE: ENOV) shares were trading at USD 21.50 on October 27, 2026, up 1.61%, with a relative volume at time of 2.30. The medical technology company received $7.7 million of 2025 tariff refunds in the quarter, recognized a $5.7 million gain on …
Ensign Group (NASDAQ: ENSG) shares were trading at USD 170.32 on October 27, 2026, down 3.73%, with a relative volume at time of 2.57. The post-acute care operator approved a share repurchase program on May 13, 2026, amended it on June 12, 2026, and …
Haemonetics (NYSE: HAE) shares were trading at USD 120.56 on October 27, 2026, up 1.15%, with a relative volume at time of 2.11. The medical technology company realigned its reportable segments into Apheresis and MedSurg on June 5, 2026, and filed its quarterly report …
Inspire Medical Systems, Inc. (NYSE: INSP) shares were trading at USD 70.45 on October 27, 2026, down 0.79%, with a relative volume at time of 2.12. The medical technology company announced Project Horizon on August 3, 2026, filed its quarterly report for the period …
Please wait processing your request...